ARGX - argenx NV ADR - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ARGX is currently covered by 22 analysts with an average price target of $666.94. This is a potential upside of $117.29 (21.34%) from yesterday's end of day stock price of $549.65.

argenx NV ADR's activity chart (see below) currently has 206 price targets and 286 ratings on display. The stock rating distribution of ARGX is 89.66% BUY and 10.34% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 91.22% with an average time for these price targets to be met of 197.46 days.

Highest price target for ARGX is $1100, Lowest price target is $510, average price target is $680.67.

Most recent stock forecast was given by DAVID NIERENGARTEN from WEDBUSH on 16-Apr-2025. First documented stock forecast 16-Nov-2017.

Currently out of the existing stock ratings of ARGX, 130 are a BUY (89.66%), 15 are a HOLD (10.34%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$715

$65.33 (10.06%)

$715

23 days ago
(16-Apr-2025)

15/17 (88.24%)

$127.41 (21.68%)

127

Buy

$720

$70.33 (10.83%)

$720

28 days ago
(11-Apr-2025)

27/30 (90%)

$139.06 (23.94%)

160

Buy

$1100

$450.33 (69.32%)

$665

1 months 29 days ago
(10-Mar-2025)

12/13 (92.31%)

$529 (92.64%)

155

Hold

$680

$30.33 (4.67%)

$650

2 months 5 days ago
(04-Mar-2025)

10/11 (90.91%)

$58.75 (9.46%)

160

Buy

$704

$54.33 (8.36%)

$675

2 months 11 days ago
(28-Feb-2025)

2/4 (50%)

$79.3 (12.69%)

56

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ARGX (argenx NV ADR) average time for price targets to be met?

On average it took 197.46 days on average for the stock forecasts to be realized with a an average price target met ratio 91.22

Which analyst has the current highest performing score on ARGX (argenx NV ADR) with a proven track record?

DANIELLE BRILL

Which analyst has the most public recommendations on ARGX (argenx NV ADR)?

Danielle Brill works at RAYMOND JAMES and has 9 price targets and 6 ratings on ARGX

Which analyst is the currently most bullish on ARGX (argenx NV ADR)?

Yatin Suneja with highest potential upside - $450.33

Which analyst is the currently most reserved on ARGX (argenx NV ADR)?

Tiago Fauth with lowest potential downside - -$330.67

argenx NV ADR in the News

argenx SE (ARGX): Among the Best Cancer Stocks to Invest in for Long-Term Gain

We recently published a list of 10 Best Cancer Stocks to Invest in for Long-Term Gains. In this article, we are going to take a look at where argenx SE (NASDAQ:ARGX) stands against other best cancer stocks to invest in for long-term gain. Surging Cancer Cases and Costs Drive Growth in the Global Oncology Market...

argenx SE (ARGX) Q1 2025 Earnings Call Highlights: Record Growth and Strategic Advances

Total Operating Income: $807 million in Q1 2025. Product Net Sales: $790 million, representing 99% growth compared to the prior year quarter. Regional Sales Breakdown: $681 million in the US, $32 million in Japan, $57 million in the rest of the world, and $20 million from product supply to Zai Lab in China. Quarter-over-Quarter Growth:...
Show more

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?